Who owns Praxis Precision Medicines, Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from company filings.
Institutional ownership of PRAX from SEC Form 13F filings across 310 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 310 institutions disclosed 33.7M shares of Praxis Precision Medicines, Inc. worth $11.29B — about 115.7% of shares outstanding; the largest disclosed holder is Jupiter Topco LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
310
13F holders
$11.29B
value, 2026 filers
115.7%
of shares outstanding (33.7M sh)
63
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30 · % of fund = share of the manager's own book · % of co. = share of PRAX's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Jupiter Topco LLCNEW | 3.4M | $1.15B | 0.5% | 11.7% | new |
| 2 | FMR LLC | 2.3M | $775.7M | 0.0% | 8% | +7.2% |
| 3 | BlackRock, Inc. | 2.3M | $767.5M | 0.0% | 7.9% | -1.4% |
| 4 | PERCEPTIVE ADVISORS LLC | 2.0M | $681.6M | 10.2% | 7% | 0.0% |
| 5 | BAKER BROS. ADVISORS LP | 1.8M | $587.0M | 2.9% | 6% | 0.0% |
| 6 | Orbis Allan Gray Ltd | 1.5M | $512.2M | 1.8% | 5.3% | -38.1% |
| 7 | VANGUARD PORTFOLIO MANAGEMENT LLC | 1.3M | $447.0M | 0.0% | 4.6% | +76.4% |
| 8 | VANGUARD CAPITAL MANAGEMENT LLC | 1.2M | $413.6M | 0.0% | 4.2% | +1.1% |
| 9 | STATE STREET CORP | 1.0M | $343.7M | 0.0% | 3.5% | +16.1% |
| 10 | ADAGE CAPITAL PARTNERS GP, L.L.C. | 1.0M | $340.0M | 0.5% | 3.5% | +24.5% |
| 11 | DEERFIELD MANAGEMENT COMPANY, L.P. | 963,351 | $322.5M | 3.4% | 3.3% | 0.0% |
| 12 | Driehaus Capital Management LLC | 959,048 | $321.1M | 1.9% | 3.3% | +1.0% |
| 13 | PRICE T ROWE ASSOCIATES INC /MD/ | 942,999 | $315.7M | 0.0% | 3.2% | +49.5% |
| 14 | MORGAN STANLEY | 854,112 | $285.9M | 0.0% | 2.9% | +2.5% |
| 15 | GEODE CAPITAL MANAGEMENT, LLC | 748,039 | $250.5M | 0.0% | 2.6% | +14.9% |
| 16 | Cormorant Asset Management, LP | 640,000 | $214.3M | 11.0% | 2.2% | -27.7% |
| 17 | GOLDMAN SACHS GROUP INC | 548,830 | $183.7M | 0.0% | 1.9% | -22.8% |
| 18 | BANK OF AMERICA CORP /DE/ | 546,930 | $183.1M | 0.0% | 1.9% | +2.3% |
| 19 | Invesco Ltd. | 537,548 | $180.0M | 0.0% | 1.8% | +775.5% |
| 20 | Hood River Capital Management LLC | 425,167 | $142.3M | 1.0% | 1.5% | +18.6% |
| 21 | NORGES BANKNEW | 346,969 | $116.2M | 0.0% | 1.2% | new |
| 22 | FRANKLIN RESOURCES INC | 327,124 | $109.5M | 0.0% | 1.1% | +18.5% |
| 23 | Pictet Asset Management Holding SA | 291,689 | $98.0M | 0.1% | 1% | +1.8% |
| 24 | Polar Capital Holdings PlcNEW | 279,131 | $93.5M | 0.2% | 1% | new |
| 25 | Vivo Capital, LLC | 271,116 | $90.8M | 8.3% | 0.9% | -20.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.